susceptibility genes

Related by string. susceptibility gene * Susceptibility : confer susceptibility . antimicrobial susceptibility testing . susceptibility locus . antimicrobial susceptibility / Genes . GENE . GeneEd : By GENE JOHNSON . gene expression patterns . gene expression profiling * breast cancer susceptibility genes . autism susceptibility genes . obesity susceptibility genes *

Related by context. All words. (Click for frequent words.) 75 susceptibility gene 70 gene variants 70 chromosomal regions 69 genetic variants 69 polymorphisms 69 autism susceptibility genes 68 genetic variations 68 genetic loci 68 germline mutations 68 CNVs 67 mutations 67 genetic polymorphisms 67 susceptibility loci 67 microdeletions 67 genetic determinants 67 Genetic variants 66 gene mutations 66 genetic variants associated 66 loci 66 susceptibility locus 66 mutated genes 66 missense mutations 65 endophenotypes 65 PTEN mutations 65 genetic mutations 65 sporadic ALS 65 FTLD 65 phenotypes 65 causal variants 65 MYH9 65 #q#.# [002] 65 chromosomal alterations 65 #q#.# [001] 65 SNPs 65 LRRK2 gene 64 inherited mutations 64 #q# [001] 64 somatic mutations 64 causative genes 64 genetic abnormalities 64 genetic markers 64 prognostic markers 64 #p#.# [001] 64 spontaneous mutations 64 epigenetic changes 64 PTPN# 64 hereditary predisposition 64 phenotypic variation 63 chromosome #q# [001] 63 PALB2 63 genetic susceptibility 63 chromosome #p#.# 63 modifier genes 63 genotypes 63 alleles 63 MYH9 gene 63 microdeletion 63 mosaicism 63 SLC#A# [002] 63 causative gene 63 TGFBR1 * 6A 63 genes 63 genetic underpinnings 62 biologic pathways 62 genomewide 62 virulence genes 62 MAPK pathway 62 chromosomal translocations 62 MTHFR 62 LIS1 62 genetic polymorphism 62 neuropsychiatric diseases 62 genomic alterations 62 phenotype 62 mitochondrial mutations 62 chromosomal rearrangement 62 aneuploidies 62 mitochondrial disorders 62 etiologic 62 epigenetic mechanisms 62 #p#.# [002] 62 neuropsychiatric disorders 62 Genetic variations 62 mitochondrial dysfunction 62 VHL gene 62 CDH1 62 underlying pathophysiology 62 TCF#L# gene 62 genetic variation 62 molecular abnormalities 62 causative mutations 62 epigenetic alterations 62 biological pathways 62 APOE e4 62 de novo mutations 62 chromosome #p# [001] 61 K ras mutations 61 PICALM 61 biomarkers 61 LRRK2 mutations 61 genomic variation 61 MGUS 61 gene rearrangements 61 #q# [002] 61 genetic alterations 61 tumor suppressor genes 61 molecular pathways 61 miRNAs 61 gene polymorphisms 61 DNA methylation patterns 61 APOE4 61 genetic modifiers 61 CYP#D# gene 61 HLA DRB1 61 SE alleles 61 familial pancreatic cancer 61 FGFR2 61 EGFR mutations 61 chromosome #q#.# [001] 61 gene locus 61 imprinted genes 61 herpesviruses 61 chromosome #q# [002] 61 epigenetic regulation 61 ataxias 61 subtypes 61 QTLs 60 TCF#L# 60 inherited predisposition 60 C#Y 60 diagnostic biomarker 60 Li Fraumeni 60 neurodevelopmental disorders 60 MLH1 60 molecular underpinnings 60 rs# [001] 60 monogenic 60 splice variants 60 gene loci 60 pathogenic mechanisms 60 BARD1 60 narcolepsy cataplexy 60 JAK mutations 60 chromosome #q 60 splice junctions 60 IKZF1 60 MECP2 gene 60 CDKN2A 60 Li Fraumeni syndrome 60 KLF4 60 polymorphism 60 genomic deletions 60 genetic predisposition 60 methylation patterns 60 #p# [001] 60 APOL1 60 homologs 60 TMEM#B 60 rs# [003] 60 GBA mutations 60 UGT#B# 60 FLT3 60 neuronal dysfunction 60 underlying molecular mechanisms 60 quantitative trait loci 60 genetic locus 60 functional polymorphism 60 cellular pathways 60 CNTNAP2 60 p# mutations 60 genetic variant 60 chromosomal abnormalities 60 mutation 60 SNP rs# [001] 60 CALHM1 60 DLX5 59 protein kinases 59 familial adenomatous polyposis 59 genetic susceptibilities 59 hypermethylation 59 genetic syndromes 59 genomic instability 59 basal cell nevus syndrome 59 alpha synuclein gene 59 familial ALS 59 molecular markers 59 mtDNA mutations 59 molecular biomarkers 59 genes predisposing 59 miRNA genes 59 familial predisposition 59 dopamine receptor gene 59 SMAD4 59 recessive mutations 59 autoimmune disorders 59 microRNA expression 59 molecular subtypes 59 haplotypes 59 susceptibility alleles 59 haplotype 59 pathogenesis 59 neuroinflammation 59 autosomal recessive disease 59 autosomal 59 neuroligins 59 distinct subtypes 59 familial clustering 59 CYP#E# gene 59 testicular germ cell 59 tumor suppressor protein 59 G#S mutation 59 apoE4 59 PARP inhibition 59 Genetic variation 59 MSH2 59 5 HTTLPR 59 lysosomal storage diseases 59 genetic aberrations 59 Genetic predisposition 59 single nucleotide polymorphism 59 ZNF# 59 TACI mutations 59 gene expression patterns 59 Meckel Gruber 59 ApoE gene 59 medulloblastomas 59 clefting 59 IL#R 59 apolipoprotein E gene 59 metabolic abnormalities 58 breast cancer subtypes 58 protein misfolding 58 orthologs 58 gene variant 58 mutated gene 58 GSTM1 58 GSTP1 58 myeloproliferative neoplasms 58 hypermethylated 58 breast cancer metastasis 58 chromosomal deletions 58 rs# [004] 58 ORMDL3 58 PIK3CA 58 neuroblastomas 58 ADAM# 58 astrocytomas 58 coinfection 58 BRAF V#E 58 breast cancer susceptibility genes 58 PGRN 58 EBV infection 58 chromosomal rearrangements 58 Genetic mutations 58 herpes viruses 58 myopathies 58 inflammatory bowel diseases 58 SLC#A# [001] 58 CHEK2 58 BRAF mutation 58 STK# [002] 58 perilipin 58 gene fusions 58 multiple sclerosis psoriasis 58 FGFR1 58 epigenetic markers 58 BRCA1 mutations 58 monozygotic twins 58 neurodevelopmental disorder 58 ADPKD 58 etiology 58 phenotypic variability 58 Clusterin 58 hereditary hemochromatosis 58 gene mutation 58 phenotypic expression 58 MLL2 58 nonsense mutations 58 KIF6 gene 58 IGFBP2 58 pre malignant lesions 58 chromosomal anomalies 58 micro RNAs 58 autosomal recessive 58 HLA genes 58 allelic variants 58 ALK mutations 58 BMPR2 58 promoter hypermethylation 58 Inflammatory bowel diseases 58 homozygosity 58 5q 57 lipid abnormalities 57 transcriptional regulation 57 prognostic marker 57 Bardet Biedl syndrome 57 CCR3 57 TRAF1 C5 57 tyrosine kinases 57 gene expression profiles 57 VIPR2 57 activating mutations 57 exomes 57 KIBRA 57 miRNA expression 57 HLA B# 57 PTEN gene 57 Hakonarson 57 predictive biomarkers 57 activating mutation 57 potentially modifiable 57 chromosome #p# [002] 57 KRAS oncogene 57 #q# deletion 57 HNPCC 57 aberrant methylation 57 genes CYP#C# 57 metalloprotease 57 chromosomal anomaly 57 aetiology 57 gene 57 NF1 gene 57 enterotypes 57 causative mutation 57 etiologic factors 57 endogenous retroviruses 57 obesity insulin resistance 57 metabolic enzymes 57 pharmacologic intervention 57 HGPS 57 genes encoding 57 CFH gene 57 genomic variants 57 diagnostic biomarkers 57 syndromes 57 breast cancer genes BRCA1 57 oncogenesis 57 VEGF receptor 57 commonly mutated genes 57 ABCB1 57 subtype 57 p# mutation 57 CHD7 57 LRRK2 57 chromosome rearrangements 57 KRAS mutations 57 precursor lesions 57 nonalcoholic fatty liver 57 drug metabolizing enzymes 57 paralogs 57 dysbindin 57 IDH1 57 heterozygosity 57 inactivating mutations 57 TP# mutation 57 APOE genotype 57 etiologic agent 57 etiological factors 57 CHRNA5 57 muscular dystrophies 57 multigene 57 p# activation 57 JAK2 mutation 57 S. maltophilia 57 pathophysiological mechanisms 57 SORL1 57 mutant genes 57 myeloproliferative diseases 57 missense mutation 57 SORL1 gene 57 HLA DQ2 57 cyclin E 57 genetic biomarkers 57 gene APOE4 57 CagA 57 segmental duplications 57 chromosomal instability 57 MYCN amplification 57 myeloproliferative disorders 57 NF2 57 genetic mutation 57 ARID1A 57 protein tyrosine phosphatase 57 progranulin gene 57 uPAR 57 BRCA1 BRCA2 57 ALK inhibitors 57 frontotemporal dementia 57 degenerative neurological diseases 57 chromosomal aberrations 57 indels 57 epigenetic modification 57 malignant phenotype 56 nicotinic receptor 56 epithelial tumors 56 myeloproliferative neoplasms MPNs 56 epilepsies 56 molecular mechanisms underlying 56 noncoding RNAs 56 ALDH2 56 APOE gene 56 chronicity 56 leukodystrophies 56 FMR1 gene 56 Kufs disease 56 sCJD 56 molecular determinants 56 FGFR2 gene 56 neurodegenerative diseases 56 LRRK2 mutation 56 splice variant 56 TTR amyloidosis 56 PON1 56 GPR# [002] 56 IgA deficiency 56 heritable 56 penetrance 56 secreted proteins 56 neurocognitive impairment 56 BRAF gene 56 apolipoprotein E 56 bile acid metabolism 56 SPINK1 56 apoE 56 KIAA# 56 phenotypic traits 56 INF2 56 gene APOE 56 heritability 56 differentially expressed genes 56 Janus kinase 56 ABCB1 gene 56 MeCP2 gene 56 heterozygote 56 transcriptomes 56 vimentin 56 serine protease 56 PKM2 56 presymptomatic 56 microcephalin 56 rs# [002] 56 monogenic disorders 56 developmental abnormalities 56 clade B 56 mitochondrial gene 56 APOE ε4 56 leukaemias 56 prostate cancer CaP 56 maternally inherited 56 genomic 56 BRCA2 gene mutations 56 fronto temporal dementia 56 LRP5 56 OGG1 56 Plasmodium vivax 56 ALK gene 56 haplogroups 56 phenotypic 56 proband 56 #p# [003] 56 sequence homology 56 ERBB2 56 nongenetic 56 FGFs 56 genomic rearrangements 56 homologues 56 C. neoformans 56 IDH1 mutations 56 motor neuron diseases 56 neuropathologic 56 G6PD deficiency 56 autoantigen 56 DLC1 56 LPA gene 56 pathophysiological 56 pathogenic mutations 56 chromosome abnormality 56 tumor suppressor gene 56 gastric carcinoma 56 evolutionarily conserved 56 ApoE4 gene 56 Wnt signaling pathway 56 biomarker 56 IDH mutations 56 CGG repeats 56 conserved sequences 56 potent inhibitors 56 kinases 56 allele 56 PITX2 56 HbF 56 epigenetic 56 Polymorphisms 56 metabolic disturbances 56 phenotypic differences 56 number variations CNVs 56 chromosome aberrations 56 IRAK1 56 Wwox 56 heritable diseases 56 plasma kallikrein 56 T2D 56 5 hydroxymethylcytosine 56 GPC5 56 genome rearrangements 56 subpopulations 56 RNA sequences 56 FXTAS 56 SOD1 gene 56 respiratory viral infections 56 Alu elements 56 clusterin 56 genomes 56 biochemical mechanisms 56 SIRT1 gene 56 alexithymia 56 childhood acute lymphoblastic 56 molecular pathway 56 systemic lupus erythematosus SLE 56 essential thrombocythemia 56 DISC1 56 Genotypes 56 pilocytic astrocytomas 56 neurodegenerative disorder 55 NAFLD 55 esophageal squamous cell carcinoma 55 Epstein Barr virus EBV 55 pathogenetic mechanisms 55 ciliopathies 55 receptor gamma 55 genotype 55 SERT gene 55 Bardet Biedl Syndrome 55 genotypic 55 micro RNA 55 NFTs 55 methylenetetrahydrofolate reductase 55 selective antagonists 55 muscular dystrophy cystic fibrosis 55 proto oncogene 55 TAp# 55 APOE4 gene 55 Sjögren syndrome 55 autoimmune diseases 55 Hashimoto thyroiditis 55 oxysterols 55 microsatellite instability 55 mesotheliomas 55 DQB1 * 55 causal pathways 55 pathophysiology 55 genetic defects 55 SLITRK1 55 chromosomal disorders 55 STAT4 55 genomewide association studies 55 airway hyperresponsiveness 55 WDR# 55 NOMID 55 pDCs 55 microglial cells 55 Nonalcoholic fatty liver 55 precancerous stem cells 55 previously undescribed 55 microRNA molecules 55 genes BRCA1 55 androgen receptor AR 55 MEF2A 55 subclinical 55 neurexins 55 heterozygous 55 chromosome deletion 55 DRD2 gene 55 IDH1 mutation 55 mutational 55 autoinflammatory diseases 55 beta globin gene 55 M. pneumoniae 55 highly heritable 55 autoantibodies 55 HOX genes 55 non coding RNA 55 airway remodeling 55 G allele 55 NKX2 55 JAK2 enzyme 55 MLL gene 55 HG PIN 55 signaling cascades 55 allele frequencies 55 breast endometrial 55 heritable disorders 55 gastrointestinal dysfunction 55 HLA molecules 55 DRB1 * 55 genetic 55 neuropsychological impairments 55 colorectal tumors 55 JAK3 55 subclinical atherosclerosis 55 linkage disequilibrium 55 MIF protein 55 Htt 55 differentially expressed proteins 55 Alleles 55 aetiological 55 ccRCC 55 p# MAPK 55 small molecule inhibitors 55 predisposing factors 55 Froguel 55 mGluR5 antagonist 55 nonalcoholic steatohepatitis NASH 55 MIF gene 55 autoantigens 55 NNRTI resistance 55 NF1 55 mRNA transcripts 55 GBM tumors 55 DRD4 55 ncRNAs 55 LRAT 55 promoter methylation 55 biomarker identification 55 GSTT1 55 BRCA2 mutation 55 validate biomarkers 55 N Myc 55 heterozygotes 55 APOE 55 Apobec3 55 TNFAIP3 55 histone deacetylases 55 NKT cells 55 VKORC1 55 PALB2 gene 55 HPV subtypes 55 Pseudomonas aeruginosa infections 55 neurobiological mechanisms 55 transcriptome 55 IL#B 55 genetically inherited 55 epistasis 55 chromosome translocations 55 GPR# [001] 55 CREBBP 55 STK# gene 55 tumor suppressors 55 multi factorial disease 55 polygenic 55 huntingtin gene 55 FGFR3 55 HLA alleles 55 FOXO3a 55 mutant huntingtin protein 55 human leukocyte antigen 55 MTHFD1L gene 55 posttranslational modifications 55 SIRT3 55 p#INK#a 55 neurodegeneration 55 gastric carcinogenesis 55 SNCA 55 CFTR gene 55 primary biliary cirrhosis 55 TLR8 55 dopamine transporter gene 55 PI3 kinase 55 PI3K pathway 55 stratifying patients 55 malaria parasite genome 55 mutant allele 55 TH# cells 55 biochemical pathways 55 allelic variation 55 NF kB pathway 55 LMNA 55 colonic mucosa 55 CDK4 54 mitochondrial DNA mtDNA 54 untreated celiac disease 54 causal pathway 54 transgenic mouse model 54 inheritable diseases 54 pathophysiologic 54 GPCR targets 54 melatonin receptor 54 oncogenes 54 Cowden syndrome 54 isotypes 54 LKB1 54 proteomes 54 V#F mutation 54 BRCA2 gene 54 psychiatric disorders 54 MTHFR gene 54 CCR5 delta# 54 metabotropic glutamate receptors 54 selective inhibitors 54 ATTR CM 54 acute lymphoid leukemia 54 Mendelian disorders 54 TYMS 54 ependymomas 54 Epstein Barr Virus EBV 54 indel 54 Hutchinson Gilford progeria 54 E#F# 54 DISC1 gene 54 SH#B# 54 autosomal dominant disorder 54 autoinflammatory 54 progressive neurodegenerative disorder 54 IL 7R 54 mutated K ras 54 neurobiological underpinnings 54 tyrosine phosphorylation 54 primate genomes 54 elevated triglyceride levels 54 enteroviruses 54 familial aggregation 54 transmembrane receptor 54 neuronal stem cells 54 gene polymorphism 54 mTOR inhibitors 54 histone modifications 54 A3 adenosine receptor 54 Fibroblast Growth Factor Receptor 54 clinically heterogeneous 54 pathophysiologic mechanism 54 gut microbes 54 SNP rs# [002] 54 Kinases 54 childhood leukemias 54 amyloid cascade 54 mutant proteins 54 generalized vitiligo 54 Smad3 54 DRD2 54 cystic fibrosis muscular dystrophy 54 epigenetic silencing 54 BRCA2 carriers 54 behavioral disinhibition 54 molecular mechanisms 54 carcinoid 54 neurodegenerative disease 54 transgenic mouse models 54 atypical hemolytic uremic syndrome 54 lung adenocarcinoma 54 poorer prognosis 54 T. gondii 54 amyloid deposits 54 modifiable risk 54 prognostic biomarkers 54 spontaneous mutation 54 C1q 54 TCF4 54 phylogenetic analyzes 54 regulates gene expression 54 nonhereditary 54 ApoE4 54 serine threonine kinases 54 L1 retrotransposons 54 biochemical abnormalities 54 autoantibody 54 coding exons 54 metabolic abnormality 54 HFE gene 54 N acetyltransferase 54 neoplastic 54 nucleoli 54 SCN5A 54 Gorlin syndrome 54 human microbiome 54 adult neurogenesis 54 hamartomas 54 microRNA genes 54 neurodegenerative illnesses 54 pleiotropic effects 54 parkinsonism 54 AAT deficiency 54 ankyrin repeat 54 pseudogenes 54 Dravet syndrome 54 MHC genes 54 mitochondrial toxicity 54 fibrodysplasia ossificans progressiva 54 periodontal infections 54 gene MECP2 54 Cytomegalovirus CMV 54 Genetic mutation 54 PPARg 54 AKT1 54 prognostic indicators 54 oncogenic 54 antisense inhibitors 54 NLRP3 54 TP# mutations 54 #S rRNA 54 receptor gene 54 mammary cells 54 Raf MEK ERK 54 protein kinase C 54 virulence determinants 54 superinfection 54 mutated BRCA1 54 tumor subtypes 54 BRCA mutation 54 nucleotide sequence 54 non syndromic 54 prostate carcinogenesis 54 Neurofibromatosis type 54 HSV1 54 Leukemias 54 karyotypes 54 MECP2 54 HOTAIR 54 multisystem disease 54 motor neuron degeneration 54 signaling pathways 54 serotonin receptor 54 VNTR 54 humanin 54 NS4A 54 suppressor gene 54 CCL#L# 54 NPHP 54 haplotype map 54 synaptogenesis 54 microbiomes 54 neurexin 54 cardiometabolic disorders 54 mutated protein 54 apoptotic pathway 54 Dpp 54 mitochondrial diseases 54 neuropsychiatric disorder 54 pathological hallmark 54 methyltransferases 54 monozygotic twin 54 insertions deletions 54 leptin deficiency 54 Arabidopsis genes 54 sortilin 54 WT1 54 nephronophthisis 54 Lenzenweger 54 transient receptor 54 OPRM1 54 CXCL5 54 TOMM# 54 probands 54 dysregulation 54 homozygotes 54 CNTNAP2 gene 54 PB1 F2 54 EGFR gene 54 synaptic function 54 IL#B gene 54 neuroinflammatory 54 genome 54 observable traits 54 neurofibromatosis type 54 EoE 54 hyper IgE syndrome 54 Karayiorgou 54 cardiac channelopathies 54 TNF blocker therapy 54 TOP2A 54 Chronic lymphocytic leukemia 54 EGFR inhibitors 54 etiologies 54 HLA DRB1 * 54 metazoan 54 MC4R gene 54 ANGPTL4 54 genetic alteration 54 TP# gene 54 APOE allele 54 catechol O methyltransferase 54 predisposing factor 54 NEIL1 54 SSc 54 Parkinsonian Syndromes 54 dizygotic twins 54 environmental toxicants 54 nondemented 54 prion infection 53 KIT mutations 53 constitutively expressed 53 demethylase 53 RUNX3 53 NS5A 53 metabolic pathways 53 cofactors 53 parkin gene 53 malignant transformation 53 spinal muscular atrophy SMA 53 SHANK3 gene 53 immune dysregulation 53 p tau 53 genetic heterogeneity 53 ubiquitin ligases 53 oncogenic pathways 53 recessive mutation 53 RIP1 kinase 53 carbohydrate intolerance 53 HPV# 53 abnormal glucose metabolism 53 tau gene 53 pathogen interactions 53 protein isoforms 53 GABRA2 53 atopic disorders 53 UGT#A# * 53 recessively inherited 53 oncoproteins 53 MAOA gene 53 genomic biomarker 53 ovarian hormones 53 BRIP1 53 methylation markers 53 facioscapulohumeral muscular dystrophy 53 hyperinsulinemia 53 atypical hyperplasia 53 periodontal pathogens 53 TTR gene 53 disease NAFLD 53 Vitamin D insufficiency 53 P. falciparum 53 Transcription factors 53 somatic mutation 53 NPY gene 53 primary cilia 53 γδ T cells 53 NEDD9 53 JAK2 inhibitors 53 kinase inhibitors 53 CYP#D# 53 physiologic mechanisms 53 fungal genomes 53 caveolin 53 KCNH2 53 JAK2 53 euthymic patients 53 neural crest 53 Fibroblasts 53 molecular biomarker 53 C. pneumoniae 53 Entamoeba histolytica 53 psychotic illnesses 53 epigenome 53 atherothrombosis 53 SRY gene 53 histocompatibility 53 rheumatoid arthritis multiple sclerosis 53 Phylomer ® 53 Autoimmune diseases 53 NR#A# 53 USP# 53 microRNAs 53 salivary proteins 53 endometrial cancers 53 CYP#C# [002] 53 genetic predispositions 53 chromosome #q#.# [002] 53 extramedullary 53 ribosomal protein 53 COL#A# 53 genetic abnormality 53 chemokine receptor 53 KCNQ1 53 receptor molecule 53 anemias 53 androgen deficiency 53 globin genes 53 gene expression 53 Leydig cell 53 intronic 53 downstream effectors 53 E4 variant 53 COX2 53 ncRNA 53 SHANK3 53 Activating mutations 53 gastric cancers 53 lymphocytic 53 COMT gene 53 alpha synuclein protein 53 Phenotypes 53 p#/CBP 53 beta amyloid peptides 53 proteins misfold 53 mGluRs 53 CYP#B# 53 RNAi therapeutic targeting 53 hematopoietic malignancies 53 Fragile X gene 53 IRF6

Back to home page